OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inside-Out of Complement in Cancer
Martin Kolev, Madhumita Das, Monica Gerber, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Martin Kolev, Madhumita Das, Monica Gerber, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Complosome — the intracellular complement system
Erin E. West, Claudia Kemper
Nature Reviews Nephrology (2023) Vol. 19, Iss. 7, pp. 426-439
Open Access | Times Cited: 112
Erin E. West, Claudia Kemper
Nature Reviews Nephrology (2023) Vol. 19, Iss. 7, pp. 426-439
Open Access | Times Cited: 112
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16515-16515
Open Access | Times Cited: 50
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16515-16515
Open Access | Times Cited: 50
The role of the complement system in the response to cytotoxic therapy
K Lee, Qingyang Zhang, Tatsuya Suwa, et al.
Seminars in Immunology (2025) Vol. 77, pp. 101927-101927
Open Access | Times Cited: 3
K Lee, Qingyang Zhang, Tatsuya Suwa, et al.
Seminars in Immunology (2025) Vol. 77, pp. 101927-101927
Open Access | Times Cited: 3
Complement regulators as novel targets for anti-cancer therapy: A comprehensive review
Ruchi Saxena, Elizabeth B. Gottlin, Michael J. Campa, et al.
Seminars in Immunology (2025) Vol. 77, pp. 101931-101931
Closed Access | Times Cited: 2
Ruchi Saxena, Elizabeth B. Gottlin, Michael J. Campa, et al.
Seminars in Immunology (2025) Vol. 77, pp. 101931-101931
Closed Access | Times Cited: 2
Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer
Miguel Quiralte, Arantzazu Barquín, Mónica Yagüe-Fernández, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 10
Open Access | Times Cited: 7
Miguel Quiralte, Arantzazu Barquín, Mónica Yagüe-Fernández, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 10
Open Access | Times Cited: 7
Dissection of paracrine/autocrine interplay in lung tumor microenvironment mimicking cancer cell-monocyte co-culture models reveals proteins that promote inflammation and metastasis
Asif Amin, Aabid Koul, Umer Majeed Wani, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Asif Amin, Aabid Koul, Umer Majeed Wani, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
With complements: C3 inhibition in the clinic
Martin Kolev, Tara Barbour, Scott B. Baver, et al.
Immunological Reviews (2022) Vol. 313, Iss. 1, pp. 358-375
Closed Access | Times Cited: 22
Martin Kolev, Tara Barbour, Scott B. Baver, et al.
Immunological Reviews (2022) Vol. 313, Iss. 1, pp. 358-375
Closed Access | Times Cited: 22
Limitations and potential of immunotherapy in ovarian cancer
Sandeep Kumar, Sayanti Acharya, Mahalakshmi Karthikeyan, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 4
Sandeep Kumar, Sayanti Acharya, Mahalakshmi Karthikeyan, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 4
The role of complement in tumor immune tolerance and drug resistance: a double-edged sword
Ronghui Yang, Di Fu, Aijun Liao
Frontiers in Immunology (2025) Vol. 16
Open Access
Ronghui Yang, Di Fu, Aijun Liao
Frontiers in Immunology (2025) Vol. 16
Open Access
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes
Xiaofei Zhang, Ruoxin Lan, Yongjun Liu, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Xiaofei Zhang, Ruoxin Lan, Yongjun Liu, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Regulation of immune-mediated chemoresistance in cancer by lncRNAs: an in-depth review of signaling pathways
Saade Abdalkareem Jasim, Farag M. A. Altalbawy, Subasini Uthirapathy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Saade Abdalkareem Jasim, Farag M. A. Altalbawy, Subasini Uthirapathy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Proteomic and In Silico Analyses Highlight Complement System’s Role in Bladder Cancer Immune Regulation
Tuğcan Korak, İbrahim Halil Baloğlu, Murat Kasap, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 735-735
Open Access
Tuğcan Korak, İbrahim Halil Baloğlu, Murat Kasap, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 735-735
Open Access
Proteomic analysis of blood plasma as a tool for personalized diagnosis of lung adenocarcinoma
D. Korobkov, А. С. Кононихин, Savva Semenov, et al.
Advances in molecular oncology (2025) Vol. 12, Iss. 1, pp. 96-108
Open Access
D. Korobkov, А. С. Кононихин, Savva Semenov, et al.
Advances in molecular oncology (2025) Vol. 12, Iss. 1, pp. 96-108
Open Access
The multiverse of CD46 and oncologic interactions
M. Kathryn Liszewski, John P. Atkinson
Journal of Clinical Investigation (2025) Vol. 135, Iss. 9
Open Access
M. Kathryn Liszewski, John P. Atkinson
Journal of Clinical Investigation (2025) Vol. 135, Iss. 9
Open Access
The role of the complosome in health and disease
Fang Xiao, Jixu Guo, Stephen Tomlinson, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Fang Xiao, Jixu Guo, Stephen Tomlinson, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism
Anna Felberg, Michał Bieńkowski, Tomasz Stokowy, et al.
Translational research (2024) Vol. 269, pp. 1-13
Closed Access | Times Cited: 2
Anna Felberg, Michał Bieńkowski, Tomasz Stokowy, et al.
Translational research (2024) Vol. 269, pp. 1-13
Closed Access | Times Cited: 2
Robust and consistent biomarker candidates identification by a machine learning approach applied to pancreatic ductal adenocarcinoma metastasis
Tanakamol Mahawan, Teifion Luckett, Ainhoa Mielgo Iza, et al.
BMC Medical Informatics and Decision Making (2024) Vol. 24, Iss. S4
Open Access | Times Cited: 2
Tanakamol Mahawan, Teifion Luckett, Ainhoa Mielgo Iza, et al.
BMC Medical Informatics and Decision Making (2024) Vol. 24, Iss. S4
Open Access | Times Cited: 2
Downregulation of C1R promotes hepatocellular carcinoma development by activating HIF‐1α‐regulated glycolysis
Yuying Ma, Yuehua Wang, Peng Tuo, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 11, pp. 2237-2253
Closed Access | Times Cited: 2
Yuying Ma, Yuehua Wang, Peng Tuo, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 11, pp. 2237-2253
Closed Access | Times Cited: 2
Complement is increased in treatment resistant rectal cancer and modulates radioresistance.
Rebecca O’Brien, Sebastian Meltzer, Croí E. Buckley, et al.
Cancer Letters (2024), pp. 217253-217253
Open Access | Times Cited: 2
Rebecca O’Brien, Sebastian Meltzer, Croí E. Buckley, et al.
Cancer Letters (2024), pp. 217253-217253
Open Access | Times Cited: 2
Identification of New Chemoresistance-Associated Genes in Triple-Negative Breast Cancer by Single-Cell Transcriptomic Analysis
Spyros Foutadakis, Dimitris Kordias, Giannis Vatsellas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6853-6853
Open Access | Times Cited: 1
Spyros Foutadakis, Dimitris Kordias, Giannis Vatsellas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6853-6853
Open Access | Times Cited: 1
Paraneoplastic Syndrome After Kidney Transplantation: Frequency, Risk Factors, Differences to Paraneoplastic Occurrence of Glomerulonephritis in the Native Kidney, and Implications on Long-Term Kidney Graft Function
Izabela Zakrocka, Gayatri Nair, María José Soler, et al.
Transplant International (2024) Vol. 37
Open Access | Times Cited: 1
Izabela Zakrocka, Gayatri Nair, María José Soler, et al.
Transplant International (2024) Vol. 37
Open Access | Times Cited: 1
The future of complement therapeutics
Martin Kolev, Kollu N. Rao, Michael W. Yeh, et al.
Exploration of Immunology (2024), pp. 577-615
Open Access | Times Cited: 1
Martin Kolev, Kollu N. Rao, Michael W. Yeh, et al.
Exploration of Immunology (2024), pp. 577-615
Open Access | Times Cited: 1
Combinatorial Inhibition of Complement Factor D and BCL2 for Early-Onset Colorectal Cancer
Shahrose Rahman, Arthur Affleck, Rebecca Ruhl, et al.
Diseases of the Colon & Rectum (2024)
Closed Access
Shahrose Rahman, Arthur Affleck, Rebecca Ruhl, et al.
Diseases of the Colon & Rectum (2024)
Closed Access
Enhanced Complement Expression in the Tumor Microenvironment Following Neoadjuvant Therapy: Implications for Immunomodulation and Survival in Pancreatic Ductal Adenocarcinoma
Xiaofei Zhang, Ruoxin Lan, Yongjun Liu, et al.
Research Square (Research Square) (2024)
Open Access
Xiaofei Zhang, Ruoxin Lan, Yongjun Liu, et al.
Research Square (Research Square) (2024)
Open Access
El sistema inmune y su interminable batalla contra las células tumorales: reconocimiento, eliminación y evasión de la respuesta inmune
Marcela Sofia Güitrón Aviña, Pablo César Ortiz-Lazareno, Fabiola Solorzano‐Ibarra
Revista Bio Ciencias (2024)
Open Access
Marcela Sofia Güitrón Aviña, Pablo César Ortiz-Lazareno, Fabiola Solorzano‐Ibarra
Revista Bio Ciencias (2024)
Open Access
